Table 3:
Study | Total Cholesterol | LDL Cholesterol | HDL Cholesterol | Triglycerides | ||||
---|---|---|---|---|---|---|---|---|
OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | |
GOCHA | 0.95 (0.80 – 1.14) | 0.59 | 0.93 (0.78 – 1.11) | 0.41 | 1.12 (0.94 – 1.34) | 0.20 | 0.95 (0.80 – 1.14) | 0.59 |
ISGC ICH | 0.93 (0.82 – 1.05) | 0.24 | 0.88 (0.77 – 0.99) | 0.04 | 1.15 (1.01 – 1.30) | 0.03 | 1.01 (0.89 – 1.14) | 0.84 |
GERFHS | 0.88 (0.77 – 1.01) | 0.07 | 0.85 (0.75 – 0.97) | 0.02 | 0.99 (0.86 – 1.12) | 0.84 | 1.19 (1.04 – 1.36) | 0.009 |
Fixed effects Meta-analysis | 0.92 (0.85 – 0.99) | 0.03 | 0.88 (0.81 – 0.95) | 0.002 | 1.10 (1.00 – 1.21) | 0.06 | 1.11 (0.98 – 1.23) | 0.14 |
Random Effects Meta-analysis | 0.92 (0.84 – 0.99) | 0.03 | 0.88 (0.81 – 0.95) | 0.002 | 1.08 (0.98 – 1.19) | 0.13 | 1.05 (0.93 – 1.20) | 0.42 |
Heterogeneity | I2=0% | 0.77 | I2=0% | 0.75 | I2=32% | 0.23 | I2=60% | 0.08 |
Acronyms: ICH: intracerebral hemorrhage; PRS (polygenic risk score); LDL: low-density lipoprotein; HDL: high-density lipoprotein; CI: confidence interval; GOCHA: Genetics of Cerebral Hemorrhage with Anticoagulation; ISGC: International Stroke Genetics Consortium; GERFHS: Genetic and Environmental Risk Factors for Hemorrhagic Stroke; FE: Fixed-Effects. RE: Random effects. Het-p: heterogeneity-p for the metanalysis.